GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChitogenX Inc (XCNQ:CHGX) » Definitions » Ending Cash Position

ChitogenX (XCNQ:CHGX) Ending Cash Position : C$0.04 Mil (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is ChitogenX Ending Cash Position?

ChitogenX's Ending Cash Position for the quarter that ended in Jan. 2024 was C$0.04 Mil.

ChitogenX's quarterly Ending Cash Position increased from Jul. 2023 (C$0.03 Mil) to Oct. 2023 (C$0.11 Mil) but then declined from Oct. 2023 (C$0.11 Mil) to Jan. 2024 (C$0.04 Mil).

ChitogenX's annual Ending Cash Position declined from Jan. 2022 (C$0.31 Mil) to Jan. 2023 (C$0.11 Mil) and declined from Jan. 2023 (C$0.11 Mil) to Jan. 2024 (C$0.04 Mil).

ChitogenX Ending Cash Position Historical Data

The historical data trend for ChitogenX's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChitogenX Ending Cash Position Chart

ChitogenX Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 0.30 2.38 0.31 0.11 0.04

ChitogenX Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.43 0.03 0.11 0.04

ChitogenX Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

ChitogenX's Ending Cash Position for the fiscal year that ended in Jan. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.108+-0.073
=0.04

ChitogenX's Ending Cash Position for the quarter that ended in Jan. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.111+-0.076
=0.04

ChitogenX Ending Cash Position Related Terms

Thank you for viewing the detailed overview of ChitogenX's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ChitogenX (XCNQ:CHGX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChitogenX Inc (XCNQ:CHGX) » Definitions » Ending Cash Position
Comparable Companies
XCNQ:BETR XCNQ:DRUG TSXV:RKV TSXV:XRTX XCNQ:TRYP TSXV:HEM TSXV:RP XCNQ:MESC TSXV:IOT TSX:APLI OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
CHNXF:USA
Address
16667 Hymus Boulevard, Kirkland, Montreal, QC, CAN, H9H 4R9
Website
https://www.chitogenx.com
ChitogenX Inc is a clinical-stage biotech company. It operates in one segment, which is the development of novel therapeutic soft tissue repair technologies.

ChitogenX (XCNQ:CHGX) Headlines

From GuruFocus

Top 5 3rd Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor • 10-19-2022

AXS Investments Acquires Industry's First-Ever Certified Carbon-Neutral ETF (CHGX) Expanding Its ETF and ESG Lineup

By PRNewswire PRNewswire • 03-21-2022

Top 5 4th Quarter Trades of Colorado Capital Management, Inc.

By GuruFocus Research GuruFocus Editor • 01-18-2023

IMPACTfolio, LLC Buys 3, Sells 2 in 2nd Quarter

By GuruFocus Research GuruFocus Editor • 07-06-2022